NCT01793870View on ClinicalTrials.gov

A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 15, 2013

Primary Completion Date

June 17, 2013

Study Completion Date

June 17, 2013

Conditions
Metabolic, Cardiovascular
Interventions
DRUG

Tab carvedilol 25 mg

Carvedilol 25 mg immediate release tablet

DRUG

Tab carvedilol 6.25 mg

Carvedilol 6.25 mg immediate release tablet

DRUG

Powder carvedilol up to 2.5 mg

Carvedilol up to 2.5 mg isotopically enriched drug substance powder

Trial Locations (1)

CB2 2GG

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01793870 - A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies | Biotech Hunter | Biotech Hunter